Three cancer drugs have been added to the interaction checker

Capecitabine, cetuximab and panitumumab are now listed in the interaction checker as cancer drugs and interactions can be found for all the comedications. 

• Capecitabine (Xeloda®) is an antimetabolite and is indicated for the treatment of breast neoplasms, colonic neoplasms, colorectal neoplasms and stomach neoplasms. 
• Cetuximab (Erbitux®) is an EGFR inhibitor and is indicated for the treatment of colorectal neoplasms and head and neck neoplasms. 
• Panitumumab (Vectibix®) is an EGFR inhibitor and is indicated for the treatment of colorectal neoplasms.